No Data
No Data
DexCom (DXCM), Abbott to Launch First FDA Cleared OTC CGMs
Is Abbott Laboratories (ABT) a Good Dividend Growth Stock to Buy and Hold According to Hedge Funds?
TorHoerman Law Advocates for Infants in Pivotal Missouri NEC Trial Against Formula Manufacturers
ST. LOUIS, July 3, 2024 /PRNewswire/ -- TorHoerman Law is set to begin trial on July 8, 2024, in Missouri state court. The case will focus on allegations that cow milk-based baby formula is linked to
Abbott Labs Is Maintained at Outperform by Evercore ISI Group
Abbott Labs Is Maintained at Outperform by Evercore ISI Group
7 Analysts Have This To Say About Abbott Laboratories
Analysts' ratings for Abbott Laboratories (NYSE:ABT) over the last quarter vary from bullish to bearish, as provided by 7 analysts.The following table provides a quick overview of their recent ratings
Abbott Laboratories Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/02/2024 16.35% Evercore ISI Group $125 → $120 Maintains Outperform 06/04/2024 21.19% RBC Capital $125 →